Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.06 | 17.75 |
| PEG Ratio (TTM) | -0.88 | 4.76 |
| P/S Ratio (TTM) | 3.61 | 3.12 |
| P/B Ratio (TTM) | 1.61 | -5.63 |
| P/FCF Ratio (TTM) | 7.05 | 29.38 |
| Price to 5YR AVG Earnings Ratio | 13.24 | 31.93 |
| Price to 5YR AVG FCF Ratio | -13.28 | 17.33 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.53% | 1,123.57% |
| ROE (TTM) | 14.12% | -410.46% |
| Net Profit Margin (TTM) | 32.60% | 18.52% |
| ROIC 5YR AVG | 7.17% | 9.24% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.93% | 627.32% | 372.31% |
| Revenue | -0.37% | 67.10% | 41.85% |
| Net Income | -1.09% | 631.04% | 374.58% |
| Cash Flow | 8.98% | 86.06% | 48.02% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.57 | 0.88 |
| Quick Ratio (TTM) | 2.54 | 0.71 |
| D/E Ratio (TTM) | 2.14 | -3.18 |
| Interest Coverage (TTM) | 1.93 | 3.70 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 0.80 | 1.42 |
| LTL to 5YR AVG FCF | -17.14 | 5.03 |
| Shares Outstanding Growth 5YR AVG | 6.60% | 6.47% |